HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Qiming Wang Selected Research
Qiming Wang Research Topics
Disease
47
Neoplasms (Cancer)
10/2022 - 10/2010
29
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 07/2010
13
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 12/2016
13
Lung Neoplasms (Lung Cancer)
04/2022 - 03/2012
9
Neoplasm Metastasis (Metastasis)
01/2022 - 03/2012
8
Disease Progression
10/2022 - 01/2012
8
Adenocarcinoma of Lung
06/2022 - 01/2012
7
Hypertension (High Blood Pressure)
10/2022 - 11/2018
6
Fatigue
10/2022 - 01/2020
5
Obesity
01/2021 - 01/2016
5
Breast Neoplasms (Breast Cancer)
01/2021 - 01/2016
4
Infections
01/2021 - 01/2020
4
Esophageal Squamous Cell Carcinoma
01/2019 - 11/2011
3
Diarrhea
01/2022 - 01/2019
3
Inflammation (Inflammations)
01/2021 - 10/2020
3
Carcinoma (Carcinomatosis)
01/2021 - 01/2018
3
Lymphatic Metastasis
01/2019 - 08/2014
3
Stomach Neoplasms (Stomach Cancer)
09/2015 - 03/2013
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2021
2
Exanthema (Rash)
01/2022 - 11/2021
2
Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 01/2021
2
Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2020
2
Hepatitis B
01/2020 - 01/2019
2
Fibrosis (Cirrhosis)
01/2020 - 01/2019
2
Hand-Foot Syndrome
01/2019 - 11/2018
2
Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019 - 01/2018
2
Mucoepidermoid Carcinoma
01/2019 - 05/2017
2
Prostatic Neoplasms (Prostate Cancer)
01/2017 - 01/2002
2
Radiation Pneumonitis
07/2014 - 03/2013
1
Male Breast Neoplasms (Male Breast Cancer)
10/2022
1
Retinoblastoma (Glioblastoma, Retinal)
01/2022
1
Cardiomegaly (Heart Hypertrophy)
01/2022
1
Weight Loss (Weight Reduction)
01/2022
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1
Brain Neoplasms (Brain Tumor)
01/2022
1
Pleural Effusion (Pleural Effusions)
11/2021
1
Pre-Eclampsia (Preeclampsia)
11/2021
Drug/Important Bio-Agent (IBA)
13
anlotinib
IBA
10/2022 - 01/2018
11
Tyrosine Kinase Inhibitors
IBA
10/2022 - 10/2010
10
Biomarkers (Surrogate Marker)
IBA
01/2022 - 11/2011
9
ErbB Receptors (EGF Receptor)
IBA
06/2022 - 10/2010
9
Proteins (Proteins, Gene)
FDA Link
01/2021 - 08/2014
7
Pharmaceutical Preparations
IBA
02/2020 - 05/2015
6
Platinum
IBA
04/2022 - 01/2012
6
MicroRNAs (MicroRNA)
IBA
01/2022 - 03/2012
5
Cisplatin (Platino)
FDA Link
Generic
08/2020 - 01/2012
4
Long Noncoding RNA
IBA
01/2022 - 01/2020
4
Gefitinib (Iressa)
FDA Link
01/2022 - 01/2012
4
Messenger RNA (mRNA)
IBA
01/2022 - 01/2017
4
Crizotinib
IBA
01/2021 - 01/2018
4
Anaplastic Lymphoma Kinase
IBA
12/2020 - 01/2018
4
Small Interfering RNA (siRNA)
IBA
01/2017 - 09/2015
3
aumolertinib
IBA
06/2022 - 01/2022
3
Phosphotransferases (Kinase)
IBA
06/2022 - 10/2020
3
Etoposide (VP 16)
FDA Link
Generic
01/2022 - 01/2021
3
osimertinib
IBA
10/2021 - 01/2021
3
Biological Products
IBA
01/2021 - 10/2016
3
Interferons
IBA
01/2020 - 10/2016
2
camrelizumab
IBA
01/2022 - 01/2022
2
Carboplatin (JM8)
FDA Link
Generic
01/2022 - 02/2015
2
Circular RNA
IBA
11/2021 - 10/2021
2
Immune Checkpoint Inhibitors
IBA
08/2021 - 01/2021
2
apatinib
IBA
02/2021 - 01/2019
2
Cell-Free Nucleic Acids
IBA
02/2021 - 10/2019
2
Therapeutic Uses
IBA
01/2021 - 01/2021
2
Capsules (Microcapsules)
IBA
01/2021 - 08/2020
2
GSK1210151A
IBA
10/2020 - 01/2020
2
Pro-Opiomelanocortin (Proopiomelanocortin)
IBA
10/2020 - 01/2018
2
Ligands
IBA
08/2020 - 01/2017
2
Glucose (Dextrose)
FDA Link
Generic
01/2020 - 01/2017
2
Cholesterol
IBA
01/2019 - 02/2015
2
Insulin (Novolin)
FDA Link
12/2017 - 01/2017
2
Survivin
IBA
10/2016 - 01/2016
2
3' Untranslated Regions (3' UTR)
IBA
09/2015 - 08/2013
1
Peptidyl Transferases (Peptidyltransferase)
IBA
10/2022
1
Tyrosine (L-Tyrosine)
FDA Link
06/2022
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2022
1
Aspartate-tRNA Ligase
IBA
01/2022
1
Immunoglobulins (Immunoglobulin)
IBA
01/2022
1
Monoclonal Antibodies
IBA
01/2022
1
Cyclin-Dependent Kinase 4
IBA
01/2022
1
6-methyladenine
IBA
01/2022
1
Programmed Cell Death 1 Receptor
IBA
01/2022
1
Enzymes
IBA
11/2021
1
B7-H1 Antigen
IBA
10/2021
1
Histocompatibility Antigens Class I
IBA
10/2021
1
ginsenoside Rb1
IBA
01/2021
1
pembrolizumab
IBA
01/2021
1
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
01/2021
1
Mitogen-Activated Protein Kinases
IBA
01/2021
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2021
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2021
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2021
1
Epidermal Growth Factor (EGF)
IBA
01/2021
1
mitogen and stress-activated protein kinase 1
IBA
01/2021
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
01/2021
Therapy/Procedure
34
Therapeutics
10/2022 - 10/2010
19
Drug Therapy (Chemotherapy)
10/2022 - 01/2012
5
Radiotherapy
10/2022 - 03/2013
5
Immunotherapy
04/2022 - 05/2019